1. 96-Week Results of Abacavir/Lamivudine versus Tenofovir/Emtricitabine, plus Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: Assert Study. Issue 7 (October 2013) Authors: Moyle, Graeme J; Stellbrink, Hans-Jürgen; Compston, Juliet; Orkin, Chloe; Arribas, José R; Domingo, Pere; Granier, Catherine; Pearce, Helen; Sedani, Sangeeta; Gartland, Martin Journal: Antiviral therapy Issue: Volume 18:Issue 7(2013) Page Start: 905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients. (15th December 2015) Authors: Walmsley, Sharon; Baumgarten, Axel; Berenguer, Juan; Felizarta, Franco; Florence, Eric; Khuong-Josses, Marie-Aude; Kilby, J. Michael; Lutz, Thomas; Podzamczer, Daniel; Portilla, Joaquin; Roth, Norman; Wong, Deborah; Granier, Catherine; Wynne, Brian; Pappa, Keith Journal: Journal of acquired immune deficiency syndromes Issue: Volume 70:Number 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correction: Dolutegravir/Abacavir/Lamivudine versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study. Issue 5 (July 2017) Authors: Trottier, Benoît; Lake, Jordan E; Logue, Ken; Brinson, Cynthia; Santiago, Lizette; Brennan, Clare; Koteff, Justin A; Wynne, Brian; Hopking, Judy; Granier, Catherine; Aboud, Michael Journal: Antiviral therapy Issue: Volume 22:Issue 5(2017) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials. (14th January 2015) Authors: Raffi, François; Rachlis, Anita; Brinson, Cynthia; Arasteh, Keikawus; Górgolas, Miguel; Brennan, Clare; Pappa, Keith; Almond, Steve; Granier, Catherine; Nichols, W. Garrett; Cuffe, Robert Liam; Jr, Joseph Eron; Walmsley, Sharon Journal: AIDS Issue: Volume 29:Number 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dolutegravir/Abacavir/Lamivudine versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study. Issue 4 (May 2017) Authors: Trottier, Benoît; Lake, Jordan E; Logue, Ken; Brinson, Cynthia; Santiago, Lizette; Brennan, Clare; Koteff, Justin A; Wynne, Brian; Hopking, Judy; Granier, Catherine; Aboud, Michael Journal: Antiviral therapy Issue: Volume 22:Issue 4(2017) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks. (28th November 2015) Authors: Tebas, Pablo; Kumar, Princy; Hicks, Charles; Granier, Catherine; Wynne, Brian; Min, Sherene; Pappa, Keith Journal: AIDS Issue: Volume 29:Number 18(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Missing CD4+ cell response in randomized clinical trials of maraviroc and dolutegravir. Issue 5 (October 2015) Authors: Cuffe, Robert; Barnett, Carly; Granier, Catherine; Machida, Mitsuaki; Wang, Cunshan; Roger, James Journal: HIV clinical trials Issue: Volume 16:Issue 5(2015) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Missing CD4+ cell response in randomized clinical trials of maraviroc and dolutegravir. Issue 5 (October 2015) Authors: Cuffe, Robert; Barnett, Carly; Granier, Catherine; Machida, Mitsuaki; Wang, Cunshan; Roger, James Journal: HIV clinical trials Issue: Volume 16:Issue 5(2015) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗